Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Relipoietin 4000IU Injection: Nurturing Red Blood Cell Production for Enhanced Vitality
Introduction:
Relipoietin 4000IU Injection serves as a therapeutic catalyst, augmenting the bone marrow's ability to generate more red blood cells. Primarily indicated for the treatment of anemia stemming from chronic kidney disease, this medication is also enlisted for combating anemia induced by cancer chemotherapy and medication-related anemia in HIV treatment. The administration, be it subcutaneous or intravenous, is typically determined by your healthcare provider and often administered by a nurse or doctor. Proper storage in a refrigerator is necessary, but the utilization should be at room temperature.
Uses of Relipoietin 4000IU Injection: Targeting Anemia at its Core
Treatment of Anemia due to Chronic Kidney Disease:
Relipoietin 4000IU Injection, a synthetic protein, facilitates the bone marrow in producing more red blood cells. It effectively addresses anemia associated with kidney disease in both adults and children undergoing dialysis. Administered post-dialysis by a healthcare professional, the injection reduces weakness and fatigue associated with anemia.
Treatment of Anemia due to Cancer Chemotherapy:
Anemia, characterized by a deficiency of red blood cells, is combated by Relipoietin 4000IU Injection through the stimulation of the bone marrow to produce more red blood cells. This is particularly crucial when the standard human form of the protein is diminished during chemotherapy for certain cancers. The injection minimizes the need for blood transfusions, potentially enhanced by iron supplements for improved efficacy.
Benefits of Relipoietin 4000IU Injection: Illuminating the Path to Health
In Treatment of Anemia due to Chronic Kidney Disease:
Offering a synthetic boost to the production of red blood cells, Relipoietin 4000IU Injection effectively manages anemia arising from kidney disease. Administered post-dialysis by a healthcare professional, it mitigates the fatigue and weakness associated with anemia.
In Treatment of Anemia due to Cancer Chemotherapy:
Operating as an erythropoiesis-stimulating agent (ESA), Relipoietin 4000IU Injection stimulates the bone marrow to produce more red blood cells. This proves instrumental during chemotherapy, reducing the reliance on blood transfusions and potentially enhanced by iron supplements for improved efficacy.
Mechanism of Action: Fostering Red Blood Cell Production
Relipoietin 4000IU Injection, classified as an erythropoiesis-stimulating agent (ESA), stimulates the bone marrow to increase the production of red blood cells. This targeted mechanism addresses anemia, ensuring a more robust and balanced red blood cell count.